Published in Am J Obstet Gynecol on April 15, 2009
Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infect Immun (2011) 0.99
Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun (2012) 0.97
O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence. Biochem J (2010) 0.91
Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization. J Infect Dis (2014) 0.84
Usefulness of a rapid real-time PCR assay in prenatal screening for group B streptococcus colonization. Ann Lab Med (2012) 0.82
Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women. Am J Reprod Immunol (2015) 0.75
Relationship between nugent score and vaginal epithelial exfoliation. PLoS One (2017) 0.75
The sialate O-acetylesterase EstA from gut Bacteroidetes species enables sialidase-mediated cross-species foraging of 9-O-acetylated sialoglycans. J Biol Chem (2017) 0.75
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Group B streptococcal neonatal and infant infections. J Pediatr (1973) 10.25
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13
The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol (1991) 2.78
Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis (1983) 2.14
Changing epidemiology of group B streptococcal colonization. Pediatrics (1999) 2.09
Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis (1982) 1.97
Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis (1977) 1.94
Group B streptococci in venereal disease clinic patients. Br J Vener Dis (1975) 1.82
Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr (1985) 1.81
Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79
Vaginal colonization with group B streptococcus: a study in college women. J Infect Dis (1977) 1.76
Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol (2000) 1.36
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med (Berl) (2005) 1.25
Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol (2002) 1.24
Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol (1979) 1.20
Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sex Transm Infect (2002) 1.17
Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis (2004) 1.14
Risk factors for group B streptococcal colonization: potential for different transmission systems by capsular type. Ann Epidemiol (2007) 1.14
Cannabinoids for gastrointestinal diseases: potential therapeutic applications. Expert Opin Investig Drugs (2003) 1.13
Determinants of co-colonization with group B streptococcus among heterosexual college couples. Epidemiology (2002) 1.08
Predictors of the vaginal microflora. Am J Obstet Gynecol (2001) 1.08
Sexual behavior and vaginal colonization by group B streptococcus among minority women. Obstet Gynecol (1996) 0.98
Associations between biologically confirmed marijuana use and laboratory-confirmed sexually transmitted diseases among African American adolescent females. Sex Transm Dis (2002) 0.96
Evaluation of a rapid enzyme immunoassay test for detection of group B Streptococcus. Obstet Gynecol (1991) 0.90
Sexual transmission and reinfection of group B streptococci between spouses. J Obstet Gynaecol Res (1999) 0.86
Streptococcus agalactiae: a vaginal pathogen? J Med Microbiol (1996) 0.86
Group B streptococcus carriage and vulvovaginal symptoms: causal or casual? A case-control study in a GUM clinic population. Sex Transm Infect (2003) 0.81
Group B streptococcal colonization in prepubertal children. Pediatrics (1979) 0.81
Can group B streptococci cause symptomatic vaginitis? Infect Dis Obstet Gynecol (1999) 0.77
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol (2002) 4.18
Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis (2003) 3.24
Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis (2003) 3.20
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol (2006) 2.56
Risk factors for primary and subsequent anal sphincter lacerations: a comparison of cohorts by parity and prior mode of delivery. Am J Obstet Gynecol (2007) 2.45
Absence of ageism in access to critical care: a cross-sectional study. Age Ageing (2003) 2.14
A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis (2008) 2.09
Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 2.09
Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis (2005) 2.04
A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol (2005) 1.94
Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol (2002) 1.85
Episiotomy and increase in the risk of obstetric laceration in a subsequent vaginal delivery. Obstet Gynecol (2008) 1.73
Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol (2002) 1.73
Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis (2005) 1.72
Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect (2007) 1.70
Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis (2003) 1.70
Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol (2004) 1.65
Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis (2004) 1.65
Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol (2007) 1.63
Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr (2009) 1.61
Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis (2005) 1.60
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc Natl Acad Sci U S A (2003) 1.56
Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model. Sex Transm Dis (2002) 1.54
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Contraception (2006) 1.52
Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis (2003) 1.44
Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis (2003) 1.38
The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis (2006) 1.35
Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One (2011) 1.28
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens. J Clin Microbiol (2003) 1.26
Why women douche and why they may or may not stop. Sex Transm Dis (2003) 1.26
Primary care physician attitudes regarding sexually transmitted diseases. Sex Transm Dis (2002) 1.25
Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol (2004) 1.24
The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study. J Acquir Immune Defic Syndr (2006) 1.24
Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol (2002) 1.24
Limitations of the dye-based method for determining vaginal applicator use in microbicide trials. Sex Transm Dis (2009) 1.24
Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol (2004) 1.21
Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol (2004) 1.20
Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials. Sex Transm Dis (2005) 1.19
Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. J Infect Dis (2005) 1.16
Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol (2012) 1.13
Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis (2007) 1.12
DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol (2003) 1.11
Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol (2003) 1.10
Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol (2003) 1.09
Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am J Epidemiol (2005) 1.09
Improved methods for typing nontypeable isolates of group B streptococci. Int J Med Microbiol (2002) 1.09
Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis (2009) 1.08
Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol (2003) 1.08
Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol (2003) 1.08
Development of a nonhuman primate model for Trichomonas vaginalis infection. Sex Transm Dis (2006) 1.08
Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque. Sex Transm Dis (2006) 1.07
Quantitative survival of aerobic and anaerobic microorganisms in Port-A-Cul and Copan transport systems. J Clin Microbiol (2008) 1.07
Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol (2005) 1.06
Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies. Cytokine (2011) 1.05
Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol (2012) 1.03
DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol (2005) 1.03
Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis (2009) 1.03
Comparison of API 50 CH strips to whole-chromosomal DNA probes for identification of Lactobacillus species. J Clin Microbiol (2005) 1.02
Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol (2012) 1.01
Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis. J Reprod Immunol (2008) 1.01
Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr Perinat Epidemiol (2007) 1.01
Association between elevated neutrophil defensin levels and endometritis. J Infect Dis (2002) 1.01
The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol (2005) 1.00
Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril (2003) 1.00
Permeability of tritiated water through human cervical and vaginal tissue. J Pharm Sci (2004) 1.00
HIV-1 infection of female genital tract tissue for use in prevention studies. J Acquir Immune Defic Syndr (2013) 0.99
Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. J Antimicrob Chemother (2004) 0.99
First-trimester cervical inflammatory milieu and subsequent early preterm birth. Am J Obstet Gynecol (2009) 0.99
Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am J Obstet Gynecol (2007) 0.99
Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis (2006) 0.98
Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol (2003) 0.97
Elevated vaginal pH and neutrophils are associated strongly with early spontaneous preterm birth. Am J Obstet Gynecol (2003) 0.97
Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol (2003) 0.97
Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies. J Med Primatol (2004) 0.97
Tumor necrosis factor-alpha promoter gene polymorphism -308 and chorioamnionitis. Obstet Gynecol (2003) 0.95
Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. J Pharm Sci (2008) 0.95
A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film. J Acquir Immune Defic Syndr (2016) 0.95
Knowledge about sexually transmitted diseases in women among primary care physicians. Sex Transm Dis (2005) 0.94
Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol (2010) 0.94
Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis (2005) 0.93